HMNC Brain Health

Industry

  • Pharmaceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • Digital Health
    • Artificial Intelligence
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
See more in Biomedtracker

Latest on HMNC Brain Health

Scrip

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur

In Vivo

Rentschler’s New CEO On 2024 Expectations For CDMOs

 
• By Lucie Ellis-Taitt

An economist by training with a lengthy career in medtech and pharma, Benedikt von Braunmühl is well placed to provide a candid view of the contract development and manufacturing market. He took the h